From Aesthetics to Expanding Therapeutic

OBI-858 serves as the cornerstone of Obigen Pharma's development strategy, extending the value of long-acting botulinum toxin beyond aesthetic medicine into a broad range of therapeutic applications.

• Aesthetic Market

  Entering high-growth aesthetic markets with a next-generation long-acting botulinum toxin product.

• Therapeutic Indications

  Expanding into neurology, urology, and other therapeutic areas to unlock the broader potential of botulinum toxin therapy.

• Global Expansion

  Global Expansion Advancing commercialization across key markets in North America, Europe, and Asia through strategic partnerships and a global supply network.